Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-05

Clinical Trial Update: Eszopiclone in the Treatment of Insomnia and Fibromyalgia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on eszopiclone for fibromyalgia and insomnia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (eszopiclone)

Snippet

Sponsor: Lesley A. Allen, Ph.D. | Conditions: Fibromyalgia, Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2021-01-05